Strengthening Defense & Security Innovation

Exosens secures €140 million in EIB financing to foster innovation in Europe’s defense and security industry

Photonis, Xenics and El-Mul are now unified under the Exosens brand. Read more →

Exosens secures €140 million in EIB financing to foster innovation in Europe’s defense and security industry

PRESS RELEASE
MÉRIGNAC, FRANCE, June 25, 2026

  • EIB financing will support Exosens’ investments in advanced night vision and imaging technologies serving European defense, surveillance, and industrial end markets, which benefit from strong structural growth drivers
  • This facility supports Exosens’ continued technology development and industrial footprint in Europe, in line with the EIB’s strategic priorities on innovation, strategic autonomy and industrial sovereignty. It is backed by the InvestEU programme
  • Exosens is uniquely positioned as a trusted, ITAR-free strategic supplier of critical, high value-added photonics solutions supporting the European defense ecosystem

Exosens (EXENS; FR001400Q9V2), a high-tech company specializing in mission- and performance-critical amplification, detection, and imaging technologies, today announces it has secured a €140 million financing facility with the European Investment Bank (“EIB”) to support the Group’s research, development, and innovation activities, as well as selected industrial investments serving European defense, surveillance, and industrial end markets, which benefit from strong structural growth drivers.

This financing, which is backed by the European Commission’s InvestEU programme, aligns with the EIB’s strategic priorities to foster technological innovation (TechEU) and strengthen Europe’s defense and security capabilities, while supporting its industrial sovereignty. It is intended to bolster Exosens’ innovation efforts and industrial investments in cutting-edge dual-use photonics technologies for night vision and imaging applications, particularly in the defense and surveillance sectors, which are critical to modern warfare and homeland security operations. The investments will support Exosens’ innovation and production capabilities across several locations, including its state-of-the-art facility in Brive-la-Gaillarde (France).

In addition, this agreement will provide the Group with access to a long-term financing instrument on favorable terms, with a maturity of up to seven years, enhancing its financial flexibility to support its growth strategy and strengthen its technological capabilities over time.

“We are delighted to receive the support of the European Investment Bank. This financing recognizes our technological leadership and strategic role within Europe’s industrial ecosystem. It will enable us to bolster our innovation efforts and industrial investments, while further strengthening our position as a trusted, ITAR-free supplier of critical dual-use photonics technologies supporting Europe’s defense and security capabilities and industrial sovereignty”, said Jérôme Cerisier, CEO of Exosens.

“The EIB quadrupled its financing for security and defense in 2025, raising it to more than 4 billion euros within the European Union, nearly 5% of the Group’s total. Our goal for 2026 is to maintain this level of ambition and reach 5% of total annual financing dedicated to security and defense. This agreement with Exosens shows that we are on the right track. France, which received 670 million last year, thus remains one of the main beneficiaries in this field”, said Ambroise Fayolle, Vice-President of the European Investment Bank.

 

Download the Press release

 

***

Next financial event
28/07/2026: H1 2026 results (before market opening).

Investor Relations
Laurent Sfaxi, l.sfaxi@exosens.com

Media Relations
Brunswick Group, exosens@brunswickgroup.com

EIB Contact
Andrea Morawski, a.morawski@eib.org, Tel.: +352 691 284 349